1-9 of 9
David Fisher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II study of acalabrutinib, venetoclax, and obinutuzumab in patients with relapsed/refractory and previously untreated Mantle Cell Lymphoma (MAVO)

Free
Austin Kim, Peter Riedell, Christine Ryan, Robert Redd, Clare Phinney, Juniper Mai, Samantha Pazienza, Caitlin Bravo, Vanessa Kats, Salah Abdulkarim, Susan Waisgerber, Reid Merryman, David Fisher, Inhye Ahn, Jennifer Crombie, Oreofe Odejide, Ann LaCasce, Caron Jacobson, Eric Jacobsen, Erin Parry, David Qualls, Amy Bessnow, Matthew S Davids, Jennifer Brown, Jon Arnason, Michael Leukam, Philippe Armand, Justin Kline, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 664.
https://doi.org/10.1182/blood-2025-664
Published: 2025
Journal Articles

Glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with high-tumor burden follicular lymphoma: First results of a multicenter phase II trial

Free
Reid Merryman, Gottfried von Keudell, Robert Redd, Heather Walker, Jenna Mahns, Samantha Normilus, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Hua-Jay Cherng, Mark Murakami, Philippe Armand, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2025-3602
Published: 2025
Journal Articles

Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trial

Free
Reid Merryman, Danielle Wallace, Robert Redd, Heather Walker, Rafaella Tringale, Vanessa Kats, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Audrey Sigmund, Inhye Ahn, Amy Bessnow, Jennifer R. Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Sumana Devata, Carla Casulo, Kami Maddocks, Mark Murakami, Philippe Armand, Yazeed Sawalha
Journal: Blood
Blood (2025) 146 (Supplement 1): 464.
https://doi.org/10.1182/blood-2025-464
Published: 2025
Journal Articles

Outcomes and prognostic factors in patients with follicular lymphoma treated with front-line bendamustine and rituximab

Free
Hari Raman, Robert Redd, Wendy Dixon, Pari Ahmadi, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Mark Murakami, Philippe Armand, Reid Merryman
Journal: Blood
Blood (2025) 146 (Supplement 1): 1812.
https://doi.org/10.1182/blood-2025-1812
Published: 2025
Journal Articles

Phase II Trial of the Oral mTOR Inhibitor RAD001 (Everolimus) in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.

Free
Irene M. Ghobrial, Renee Leduc, Marybeth Nelson, Xavier Leleu, Eric Jacobsen, Ann LaCasce, Daniel DeAngelo, David Fisher, Jennifer R. Brown, Robert Schlossman, Diane Warren, Jacob Soumerai, Kelly O’Connor, Nikhil Munshi, Paul Richardson, Kenneth C. Anderson, Thomas E. Witzig, Steven P. Treon
Journal: Blood
Blood (2007) 110 (11): 4496.
https://doi.org/10.1182/blood.V110.11.4496.4496
Published: 2007
Journal Articles

Phase II Study of SGN-30 (Anti-CD30 Monoclonal Antibody) in Patients with Refractory or Recurrent Hodgkin’s Disease.

Free
John P. Leonard, M.D., Joseph D. Rosenblatt, M.D., Nancy L. Bartlett, M.D., Ajay Gopal, M.D., Anas Younes, M.D., David Fisher, M.D., Francine Foss, M.D., Andres Forero, M.D., Steven Bernstein, M.D., Bruce Cheson, M.D., Matthew H. Carabasi, M.D., R. Gregory Bociek, M.D., Bruce Hart, Ph.D., Michael McDonald, M.D.
Journal: Blood
Blood (2004) 104 (11): 2635.
https://doi.org/10.1182/blood.V104.11.2635.2635
Published: 2004
Journal Articles

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma.

Free
Andres Forero-Torres, Steven Bernstein, Ajay Gopal, Francine Foss, John Leonard, Joseph Rosenblatt, Nancy Bartlett, Anas Younes, David Fisher, Bruce Cheson, Matthew Carabasi, Gregory Bociek, Bruce Hart, Michael McDonald
Journal: Blood
Blood (2004) 104 (11): 2637.
https://doi.org/10.1182/blood.V104.11.2637.2637
Published: 2004
Journal Articles

T-cell–depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

Free
Clinical Trials & Observations
Edwin Alyea, Edie Weller, Robert Schlossman, Christine Canning, Iain Webb, Deborah Doss, Peter Mauch, Karen Marcus, David Fisher, Andrea Freeman, Bijal Parikh, John Gribben, Robert Soiffer, Jerome Ritz, Kenneth Anderson
Journal: Blood
Blood (2001) 98 (4): 934–939.
https://doi.org/10.1182/blood.V98.4.934
Published: 2001
Journal Articles

CD6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia in First Complete Remission

Free
Robert J. Soiffer, Diane Fairclough, Michael Robertson, Edwin Alyea, Kenneth Anderson, Arnold Freedman, Lini Bartlett-Pandite, David Fisher, Robert L. Schlossman, Richard Stone, Christine Murray, Andrea Freeman, Karen Marcus, Peter Mauch, Lee Nadler, Jerome Ritz
Journal: Blood
Blood (1997) 89 (8): 3039–3047.
https://doi.org/10.1182/blood.V89.8.3039
Published: 1997